Kurian Sunil M, Stewart Darren E, Toll Alice, Checchi Kyle, Case Jamie, Marsh Christopher L
Department of Surgery, Scripps Center for Organ and Cell Transplantation, La Jolla, CA.
Scripps Clinic Biorepository and Bio-Informatics Core, La Jolla, CA.
Transplant Direct. 2022 Nov 17;8(12):e1414. doi: 10.1097/TXD.0000000000001414. eCollection 2022 Dec.
Delayed graft function (DGF) after kidney transplantation is associated with higher rates of acute rejection and poor graft survival and outcomes. Current DGF definitions based on posttransplant need for dialysis are not standardized and there are no objective methodologies for quantifying DGF severity.
Using Organ Procurement and Transplantation Network data, we examined DGF, and used recipient serum creatinine at discharge as a correlate of renal function and DGF severity (mild: <2.5 mg/dL; severe: ≥2.5 mg/dL). The associations between donor and recipient factors and DGF severity were quantified using logistic regression. We also examined the associations between DGF severity and long-term recipient outcomes, adjusting for potential confounders.
A predictive model using donor and recipient factors had a reasonably good ability to discriminate mild (low creatinine) versus severe (high creatinine) DGF (c-statistic of 0.70). In Cox regression, DGF and creatinine at discharge were both independently associated with long-term outcomes, yet their effects differed depending on the outcome (graft function, death-censored graft function, recipient mortality). Our findings suggest that having DGF, but with relatively good renal function (creatinine <2.5) at discharge, may be less deleterious on graft and recipient survival compared with severe, prolonged DGF, which was associated with a decreased median graft survival of ~2.6 y compared with no DGF with low creatinine at discharge.
Our novel DGF severity stratification identified unique factors associated with DGF severity, along with DGF's association with long-term graft and patient survival. The adverse cost and outcome implications of severe DGF warrant additional investigation to improve kidney transplantation practice.
肾移植后的移植肾功能延迟恢复(DGF)与急性排斥反应发生率较高、移植肾存活及预后不良相关。目前基于移植后透析需求的DGF定义并不标准化,且尚无量化DGF严重程度的客观方法。
利用器官获取与移植网络数据,我们对DGF进行了研究,并将受者出院时的血清肌酐作为肾功能及DGF严重程度的一个相关指标(轻度:<2.5mg/dL;重度:≥2.5mg/dL)。使用逻辑回归对供者和受者因素与DGF严重程度之间的关联进行量化。我们还研究了DGF严重程度与受者长期预后之间的关联,并对潜在混杂因素进行了校正。
一个使用供者和受者因素的预测模型对轻度(肌酐水平低)与重度(肌酐水平高)DGF具有较好的区分能力(c统计量为0.70)。在Cox回归中,DGF和出院时的肌酐均与长期预后独立相关,但其影响因预后(移植肾功能、死亡删失的移植肾功能、受者死亡率)而异。我们的研究结果表明,发生DGF但出院时肾功能相对较好(肌酐<2.5),与严重、持续性DGF相比,对移植肾和受者存活的有害性可能较小,严重、持续性DGF与出院时肌酐水平低且无DGF相比,移植肾中位存活时间减少约2.6年。
我们新的DGF严重程度分层确定了与DGF严重程度相关的独特因素,以及DGF与移植肾长期存活和患者存活之间的关联。严重DGF对成本和预后的不利影响值得进一步研究,以改善肾移植实践。